First Trust Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $258K | Buy |
14,784
+2,227
| +18% | +$44.2K | ﹤0.01% | 2497 |
|
|
2025
Q4 | $246K | Buy |
+12,557
| New | +$261K | ﹤0.01% | 2518 |
|
|
2024
Q2 | – | Sell |
-57,492
| Closed | -$2.79M | – | 2431 |
|
|
2024
Q1 | $2.79M | Buy |
57,492
+24,138
| +72% | +$1.18M | ﹤0.01% | 1586 |
|
|
2023
Q4 | $1.79M | Buy |
+33,354
| New | +$1.69M | ﹤0.01% | 1771 |
|
|
2023
Q2 | – | Sell |
-53,719
| Closed | -$3.38M | – | 2451 |
|
|
2023
Q1 | $3.38M | Buy |
53,719
+20,329
| +61% | +$1.21M | ﹤0.01% | 1433 |
|
|
2022
Q4 | $1.78M | Buy |
33,390
+5,373
| +19% | +$291K | ﹤0.01% | 1743 |
|
|
2022
Q3 | $1.57M | Sell |
28,017
-8,229
| -23% | -$544K | ﹤0.01% | 1809 |
|
|
2022
Q2 | $2.62M | Buy |
36,246
+10,371
| +40% | +$772K | ﹤0.01% | 1620 |
|
|
2022
Q1 | $2.06M | Sell |
25,875
-67
| -0.3% | -$6.04K | ﹤0.01% | 1764 |
|
|
2021
Q4 | $2.63M | Buy |
25,942
+1,785
| +7% | +$178K | ﹤0.01% | 1673 |
|
|
2021
Q3 | $2.23M | Sell |
24,157
-8,101
| -25% | -$779K | ﹤0.01% | 1729 |
|
|
2021
Q2 | $3.3M | Buy |
32,258
+18,773
| +139% | +$1.88M | ﹤0.01% | 1610 |
|
|
2021
Q1 | $1.32M | Sell |
13,485
-5,522
| -29% | -$503K | ﹤0.01% | 1893 |
|
|
2020
Q4 | $1.47M | Buy |
19,007
+9,966
| +110% | +$771K | ﹤0.01% | 1733 |
|
|
2020
Q3 | $666K | Buy |
9,041
+1,458
| +19% | +$117K | ﹤0.01% | 1931 |
|
|
2020
Q2 | $557K | Sell |
7,583
-3,449
| -31% | -$271K | ﹤0.01% | 1978 |
|
|
2020
Q1 | $637K | Sell |
11,032
-6,745
| -38% | -$469K | ﹤0.01% | 1848 |
|
|
2019
Q4 | $1.4M | Buy |
17,777
+11,237
| +172% | +$828K | ﹤0.01% | 1733 |
|
|
2019
Q3 | $447K | Buy |
+6,540
| New | +$439K | ﹤0.01% | 2168 |
|
|
2019
Q2 | – | Sell |
-39,520
| Closed | -$3.31M | – | 2508 |
|
|
2019
Q1 | $3.31M | Buy |
39,520
+2,211
| +6% | +$231K | 0.01% | 1277 |
|
|
2018
Q4 | $4.39M | Buy |
37,309
+32,145
| +622% | +$3.72M | 0.01% | 1032 |
|
|
2018
Q3 | $623K | Sell |
5,164
-2,322
| -31% | -$288K | ﹤0.01% | 2126 |
|
|
2018
Q2 | $863K | Sell |
7,486
-5,018
| -40% | -$549K | ﹤0.01% | 1990 |
|
|
2018
Q1 | $1.07M | Sell |
12,504
-11,147
| -47% | -$863K | ﹤0.01% | 1759 |
|
|
2017
Q4 | $1.75M | Buy |
23,651
+6,215
| +36% | +$416K | ﹤0.01% | 1598 |
|
|
2017
Q3 | $1.01M | Sell |
17,436
-4,102
| -19% | -$242K | ﹤0.01% | 1849 |
|
|
2017
Q2 | $1.38M | Sell |
21,538
-3,531
| -14% | -$218K | ﹤0.01% | 1708 |
|
|
2017
Q1 | $1.44M | Buy |
25,069
+12,800
| +104% | +$764K | ﹤0.01% | 1687 |
|
|
2016
Q4 | $751K | Buy |
12,269
+5,861
| +91% | +$382K | ﹤0.01% | 1962 |
|
|
2016
Q3 | $443K | Sell |
6,408
-10,052
| -61% | -$663K | ﹤0.01% | 2037 |
|
|
2016
Q2 | $917K | Buy |
+16,460
| New | +$993K | ﹤0.01% | 1748 |
|
|
2016
Q1 | – | Sell |
-4,676
| Closed | -$299K | – | 2288 |
|
|
2015
Q4 | $299K | Sell |
4,676
-94
| -2% | -$6.1K | ﹤0.01% | 2075 |
|
|
2015
Q3 | $320K | Sell |
4,770
-224
| -4% | -$15.8K | ﹤0.01% | 2077 |
|
|
2015
Q2 | $341K | Sell |
4,994
-172
| -3% | -$10.9K | ﹤0.01% | 2052 |
|
|
2015
Q1 | $287K | Buy |
+5,166
| New | +$265K | ﹤0.01% | 2078 |
|
Other funds holding USNA
NCM
VCM
VPM
First Trust Advisors's USNA Position: Q1 2026 in Review
First Trust Advisors increased its Usana Health Sciences (USNA) stake by 18% in Q1 2026, buying an estimated $44.2K and bringing the position to 14,784 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #2497.
First Trust Advisors first reported a position in USNA in Q1 2015 and has held it in 35 quarters since. The position peaked at $4.39M in Q4 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- First Trust Advisors held 14,784 shares of Usana Health Sciences worth $258K as of Q1 2026.
- First Trust Advisors bought 2,227 Usana Health Sciences shares in Q1 2026, an estimated $44.2K.
- Usana Health Sciences made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #2497 holding.
- First Trust Advisors first reported a position in Usana Health Sciences in Q1 2015 and has held it in 35 quarters since.
- First Trust Advisors's Usana Health Sciences position peaked at $4.39M in Q4 2018.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.